Inflammatory Bowel Disease Promotes Venous Thrombosis Earlier in Life

References

• References
   Google Scholar
• Bargen JA, Barker NW. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936;58:17–31.
   Google Scholar
• Ricketts WE, Palmer WL. Complications of chronic nonspecific ulcerative colitis. Gastroenterology 1946;7:55–6.
   PubMed Web of Science ®Google Scholar
• Dennis C, Karlson KE. Surgical measures as supplements to the management of idiopathic ulcerative colitis: cancer, cirrhosis and arthritis as frequent complications. Surgery 1952;32:892–912.
   PubMed Web of Science ®Google Scholar
• Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III Complications. Gut 1964;5:1–15.
   PubMed Web of Science ®Google Scholar
• Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986;61:140–5.
   PubMed Web of Science ®Google Scholar
• Reynolds J. Corticosteroids. In: Martindale, the extra pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society; 1996. p. 1017–36.
   Google Scholar
• Lake AM, Stauffer JQ, Stuart MJ. Hemostatic alterations in inflammatory bowel disease. Response to therapy. Dig Dis 1978;23:897–902.
   Google Scholar
• Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE. Evidence for activation of coagulation in Crohn’s disease. Blood Coagul Fibrinolysis 1992;3:773–8.
   PubMed Web of Science ®Google Scholar
• Jorens PG, Hermans CR, Haber I, Kockx MM, Vermylen J, Parizel GA. Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis. Blut 1990;61:307–10.
   PubMedGoogle Scholar
• Edwards RL, Levine JB, Green R, Duffy M, Mathews E, Brande W, et al. Activation of blood coagulation in Crohn’s disease. Increased plasma fibropeptide A levels and enhanced generation of monocyte tissue factor activity. Gastroenterology 1987;92:329–37.
   Google Scholar
• Stevens TRJ, James JP, Simmonds NJ, McCarthy DA, Laurenson IF, Maddison PJ, et al. Circulating von Willebrand factor in inflammatory bowel disease. Gut 1992;33:502–6.
   PubMed Web of Science ®Google Scholar
• Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzales D, et al. Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40:1883–9.
   PubMed Web of Science ®Google Scholar
• Liebman HA, Kashani N, Sutherland D, McGehee W, Kam L. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998;115:830–4.
   Google Scholar
• Zoller B, Holm J, Dahlback B. Resistance to activated protein C due to a factor V gene mutation. The most common inherited risk factor of thrombosis. Trends Cardiovasc Med 1996;6:45–53.
   Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–703.
   PubMed Web of Science ®Google Scholar
• Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, et al. Frequent factor II G20210A mutation in idiopatic portal vein thrombosis. Gastroenterology 1999;116:144–8.
   PubMed Web of Science ®Google Scholar
• O’Morain C, Tobin A, Leen E, Suzuki Y, O’Riordan T. Criteria of case definition in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 1989;24 Suppl 170:7–11.
   Google Scholar
• Svensson PJ, Zöller B, Mattiasson I, Dahlbäck B. The factor V:R506Q mutation causing APC resistance is highly prevalent among unselected outpatients with clinically suspected deep venous thrombosis. J Intern Med 1997;241:379–85.
   PubMed Web of Science ®Google Scholar
• Hillarp A, Zöller B, Svensson PJ, Dahlbäck B. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis. Thromb Haemost 1997;78:990–2.
   PubMed Web of Science ®Google Scholar
• Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboemboloic disease—critical evaluation of laboratory investigation. Thromb Haemost 1992;68:7–13.
   PubMed Web of Science ®Google Scholar
• Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–8.
   Google Scholar
• Zoller B, Svensson PJ, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis prone families with inherited resistance to activated protein C. J Clin Invest 1994;94: 2521–4.
   Google Scholar
• Tysk C, Järnerot G. Ulcerative proctocolitis in (Örebro, Sweden. A retrospective epidemiologic study, 1963–1987. Scand J Gasteroenterol 1992;27: 945–50.
   Google Scholar
• Lindberg E, Järnerot G. The incidence of Crohn’s disease is not decreasing in Sweden. Scand J Gasteroenerol 1991;26:495–500.
   PubMed Web of Science ®Google Scholar
• Lapidus A, Bernell O, Hellers G, Persson PG, Löfberg R. Incidence of Crohn’s disease in Stockholm county 1955–1989. Gut 1997;41: 480–6.
   Google Scholar
• Stein B, Fuster V. Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism. Am J Cardiol 1989;64:33B–40B.
   Google Scholar
• Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ 1992;305:567–74.
   Google Scholar
• Nordström M, Lindblad B, Bergquist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155–60.
   Google Scholar
• Jackson LM, O’Gorman PJ, O’Connell J, Cronin CC, Cotter KP, Shanahan F. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and Factor V Leiden. Q J Med 1997;90:183–8.
   Google Scholar
• Aadland E, Ødegaard OR, Roseth A, Try K. Free protein S deficiency in patients with Crohn’s disease. Scand J Gastroenterol 1994;29:333–5.
   PubMed Web of Science ®Google Scholar
• Koster T, Rosendaal FR, Briet E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis. Blood 1995;85:2756–61.
   Google Scholar
• Kjeldsen J, Lassen JF, Brandslund I, Schaffalitzky de Muckadell OB. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. Scand J Gastroenterol 1998;33:637–43.
   Google Scholar
• Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994;70: 863–70.
   Google Scholar
• Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, et al. Hemostatic abnormalities in inflammatory bowel disease. Tromb Res 1996;82:137–46.
   PubMed Web of Science ®Google Scholar